Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 677

Emailed: 0

PDF Downloaded: 1007


Shah and Patel: Evaluation of bone marrow in patients with pancytopenia


Introduction

Pancytopenia is common hematological term described as decreased red blood cells, white blood cells and platelets caused by either reduced production of haematopoietic cells in bone marrow or secondary destruction or reduction by drugs, toxins, radiotherapy, chemotherapy, infection etc.1, 2 Laboratory parameters are-haemoglobin< 9 gm/dl, WBC < 4,000/cmm, and platelets < 1,00,000/cmm.1 Clinical signs and symptoms are pallor, fatigue, dyspnoea, bleeding or bruising, susceptibility to infection, organ and lymphnode enlargement.1

The diagnosis of pancytopenia is challenge and requires cooperation of both clinician and pathologist.3 It also give comments on disease stage, progression if any, management & prognosis.4 The clinician has to apply comprehensive approach by detailed analysis of history, laboratory parameters and bone marrow study to reach correct cause of new onset pancytopenia.

BMA and BMB are complimentary with each other when used together for evaluation of bone marrow in routine haematological disorders. This study is done to statistically analyze the diagnostic value of both procedures and the lacuna observed when any one of the procedure performed alone.

Materials and Methods

Study design

This was prospective and retrospective study of 145 cases of pancytopenia conducted at pathology department of a tertiary care hospital, Ahmedabad, Gujarat, India, over a period of 36 months (January 2016-December 2018). The study was held after approval from Institutional Ethical Committee (GCSMC/EC/TRIAL/APPROVE/2017/18).

Study groups

All the patients with different age at presentation that diagnosed as new onset pancytopenia in various clinical departments of hospital during this time period were identified through clinical case records to assess whether patient met the study inclusion criteria.

Inclusion Criteria were –hemoglobin<10 gm%, total leukocyte count < 4000/cumm, platelet count< 1,50,000/cumm, new onset pancytopenia, all age groups and both sex.

Exclusion Criteria were-history of chemotherapy &/or radiotherapy and known cases of pancytopenia.

Study methods

Informed written consent was taken for BMA and BMB from the patient or guardian if minor. Peripheral smear, reticulocyte count, blood indices, prothrombin time, HIV, HBsAg tests were done before procedure. BMA was done using Salah needle no.16 for adults and no.18 for children with aseptic precautions. Aspirate was withdrawn with a 10 ml disposable plastic syringe from posterior superior iliac spine. 8-10 aspirate smears were prepared, air dried (fixed whenever required) and later stained by Leishman, Giemsa or Field stain. BMB was also done in all cases at same site by using Jamshidi needle with trocar and cannula. Biopsy material (atleast 1.5-2cm long) was sent to histopathology lab in 10% neutral buffered formalin, decalcified in 5% nitric acid, processed in routine paraffin embedding, 4-5μm thick sections were cut by Leica RM 2125 rotatory manual microtome. The slides were stained by Hematoxylin and Eosin (H&E) and then reported by pathologist using Nikon E 200 Light Microscope.

Data collected

All data including age, sex, hemoglobin, reticulocyte count, total white cell and platelet counts, clinical signs and symptoms, BMA, BMB diagnosis were collected from clinical case records of patients.

Statistical analysis

Data was entered in Microsoft excel sheets in computer. The statistical calculations were performed using a Statistical Package for the Social Sciences Version 21 (SPSS, IBM company, Chicago, USA). The results were analysed using frequency distribution. The cases were also distributed according their age, sex and presenting clinical signs and symptoms. BMA and BMB findings were also compared and analyzed.

Results

Out of 145 patients, 137 were adults and 8 were children. The mean age of the patients was 46 years.35 cases fall in to age group of 41-50 years.(Figure 1) The male to female ratio (1.1:1) was almost equal.(Figure 2) Pallor and generalized weakness were universal clinical complaints noted in all cases. The rest were fever (55%) and dyspnoea (41%). 14% and 10% patients were having enlargement of spleen and liver.(Figure 3)

The distribution of various causes of pancytopenia was shown in Table 1. The incidence of megaloblastic anemia was - 32% most frequent followed by hypoplastic marrow in 16% cases. Hypercellular bone marrow was noted in megaloblastic anemia, acute leukemia, Myelodysplastic syndrome (MDS), reactive conditions, lymphoma, immune thrombocytopenic purpura (ITP)and few cases of myeloproliferative neoplasm (MPN). However bone marrow cellularity was decreased in cases of pancytopenia caused by aplastic anemia, metastasis of unknown primary and few cases of myelofibrosis. Myeloid / Erythroid ratio (M/E ratio) was reversed in all cases of megaloblastic anemia and reactive conditions; but M/E ratio was increased in cases of Acute leukemias; however it was normal in cases of hypoplastic and aplastic anemia.

Megaloblastic anemia was observed in 46 adults with their age ranging from 10 years to 72years. Out of them, 60% had decreased levels of vitamin B12 and folic acid. Peripheral smear showed moderate anisopoikilocytosis with predominantly macrocytic normochromic red cells, few macro-ovalocytes and hypersegmented neutrophils. Bone marrow aspiration showed hypercellular marrow with megaloblastic erythropoiesis. Megaloblasts had dyserythropoiesis, sieve like nuclear chromatin and arrested nuclear-cytoplasmic maturation.(Figure 4)

BMA smears of hypoplasia (17%) were diluted with peripheral blood and showed moderate reduction of hematopoietic precursors with increased marrow fat. There were focal cellular areas of lymphocytes and plasma cells. There were 4 cases of dry tap on BMA, later reported as acute leukemia (2), aplastic anemia (1) and myelofibrosis (1) on BMB. BMA cellularity was inadequate for reporting in 4 cases of pancytopenia, later reported as aplastic anemia(1), acute leukemia(1), nonhodgkins lymphoma (NHL)(1) and myelofibrosis(1).

BMA smears of acute leukemia were hypercellular with severe reduction of erythroid, myeloid and megakaryocytic series with presence of >20% blasts.(Figure 5) Six cases of plasma cell myeloma showed increased number of lymphoid cells and presence of atypical plasma cells with hypo or hypercellular marrow.(Figure 6) Patients with bone marrow involvement by lymphoma showed severe reduction of all three lineages with presence of medium sized lymphoid cells. A possibility of bone marrow involvement by lymphoproliferative disorder was suggested in those cases and later proven as low grade nonhodgkins lymphoma by Immunohistochemistry on BMB.(Figure 7) One case of BMB showed presence of focal granulomas indicating tuberculosis as cause of pancytopenia. This was wrongly reported as megaloblastic anemia on BMA. In infective causes, one case of plasmodium falciparum malaria was detected with presence of gametocytes in the aspiration smears.

Table 1

Causes of cytopenia on bone marrow aspiration (BMA)

Diagnosis

No. of cases

% of cases

Megaloblastic anemia

49

34%

Hypoplastic anemia

33

24%

Normocellular/ Reactive marrow

14

10%

Plasma cell myeloma

6

4%

Anemia

12

9%

Acute leukemia

9

7%

Hypersplenism

2

1%

Myelodysplastic syndrome (MDS)

3

2%

Myelofibrosis

2

1%

Idiopathic thrombocytopenic purpura

2

1%

Metastases

2

1%

Malaria

1

1%

Lymphoma

2

1%

Dry tap

4

2%

Inadequate

4

2%

Total cases

145

Table 2

Comparison of findings between different studies

S.No

Study

Country

year

No. of cases

Commonest cause

Second most common cause

1

Das R et al

India

2016

64

Megaloblastic Anemia (58%)

Aplastic Anaemia (19%)

2

Singh et al

India

2017

150

Megaloblastic Anemia (49.3%)

Aplastic Anaemia (16%)

3

Jha et al

Nepal

2010

102

Hypoplastic Anaemia (42.15%)

Haematological Malignancy (19.4%)

4

Gayathri et al

India

2011

104

Megaloblastic Anemia (74.0%)

Aplastic Anaemia (18.3%)

5

Pereira A et al

India

2016

80

Megaloblastic Anemia (60%)

Aplastic Anaemia(10%)

6

Bahal N et al

India

2016

129

Megaloblastic Anemia (37%)

Haematological Malignancy (21%)

7

Rangaswamy M et al

India

2012

100

Megaloblastic Anemia (33%)

Nutritional Anaemia (16%)

8

Sweta et al

India

2014

100

Megaloblastic Anemia (66%)

Aplastic Anaemia (18%)

9

Kumar V et al

India

2018

210

Megaloblastic Anemia (62%)

Aplastic Anaemia (25%)

10

Present study

India

2019

145

Megaloblastic Anemia (32%)

Hypoplastic Anaemia (16%)

Table 3

Comparison of findings between BMA and BMB

Diagnosis

No. of cases BMB

Finding same as BMA

percentage %

Megaloblastic anemia

46

46

32

Hypoplastic anemia

25

25

17

Anemia

12

12

9

Normocellular/ Reactive marrow

17

14

12

Plasma cell myeloma

6

6

4

Acute leukemia

12

9

9

Myelofibrosis

4

2

3

Hypersplenism

2

2

1

Myelodysplastic syndrome (MDS)

3

3

2

ITP

2

2

1

Lymphoma

3

2

2

Metastases

5

2

3

Tuberculosis

1

0

0.5

Malaria

1

1

0.5

Aplastic anemia

6

0

4

Total Cases

145

126

Figure 1

Age wise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image1.png
Figure 2

Sex wise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image2.png
Figure 3

Complaint wise distribution of cases

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image3.png
Figure 4

Bone marrow aspiration smear of megaloblastic anemia (100x, Field stain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image4.png
Figure 5

Bone marrowaspiration smear of acute myeloid leukemia (100x, Field stain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image5.png
Figure 6

Bone marrow aspiration smear of plasma cell myeloma (100x, Field stain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image6.png
Figure 7

Bone marrow biopsy of low grade Nonhodgkins lymphoma (40x, H&Estain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image7.png
Figure 8

Bone marrow biopsy of aplastic anemia (10x, H&Estain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image8.png
Figure 9

Bone marrow biopsy of metastasis of adenocarcinoma from gall bladder.(40x, H&Estain)

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/2a995b83-4c6a-4f89-86b0-55720f5f1b98image9.png

Discussion

The clinician finds pancytopenia very frequently in his daily out patient departments. It results due to reduced production of red cells, white cells and platelets in bone marrow or secondary to infection, drugs-chemotherapy, radiotherapy, cancer, fibrosis etc.1

A total of 145 cases of pancytopenia were studied. The cases were studied for age and gender distribution, clinical complaints, BMA and BMB results. The findings were compared with other studies. The age of the patients ranged from 4 to 75 years, with a mean age of 46 years.(Figure 1) This findings were compared with other studies.4, 5, 6 Pancytopenias was observed more in males (54%) than females (46%)(Figure 2) with male-to-female (M: F) ratio of 1.1: 1. This male predominance observed in this study has been reported by many other similar studies. 4, 5, 7, 8, 9 The most common presenting complaint in this study was generalized weakness & pallor (100%) (Figure 3) followed by dyspnea (41%) comparable to other studies. 4, 5, 7

The most common cause of pancytopenia varied in different studies. In this study megaloblastic anemia was the most frequent (32%) cause of pancytopenia.(Table 1) Same results were seen in various other Indian studies suggesting that nutritional anemia is the most leading cause of pancytopenia in India.(Table 2)

Megaloblastic anaemia can be caused by deficiency of vitamin B12 or folic acid in diet and severity of anaemia depends on ineffective erythropoiesis.10 In this study, (Table 3) 46 out of 49 cases of it were diagnosed by both BMA and BMB. Among rest 3 cases, 2 were diagnosed as reactive bone marrow and one was of tuberculosis diagnosed later by BMB. There were mild megaloblastic changes in reactive marrow leading to false positive diagnosis on BMA. In tuberculosis, granulomas were focal and detected on BMB leading to false negative diagnosis on BMA.

Hypoplastic marrow was second most common (33cases) cause for pancytopenia in this study (Table 1) comparable to different Indian studies.(Table 2). The bone marrow were hypocellular due to aplasia, drugs, chronic viral infections, radiation, toxins and hematological malignancies.1 Aplastic anaemia marrow was hypocellular with relative increase in fat but without abnormal infiltrate or increased fibrosis.(Figure 8) 25 cases were reported same as hypoplastic anemia on BMA and BMB.(Table 3) The rest 8 cases were diagnosed as aplastic anemia(4), metastatic adenocarcinomas(3), reactive marrow (1).

Acute leukaemia-the authors noted 12 cases of acute leukemia both in children and adults in present study (Table 1). In older adults, Acute Myeloid Leukaemia was more common while acute lymphoblastic leukaemia in childhood. Peripheral blood examination showed pancytopenia with few blasts but diagnosis was established on bone marrow smear showing >20 % blasts. The findings were similar to that detected by Das R 7 et al, Pereira ADS11 et al, Pathak R 12 et al. On aspiration, dry tap &/or inadequate aspirate (3 cases) were causes for false negative diagnosis. Rest 9 cases were diagnosed by both procedures& thus showing complimentary role to each other. (Table 3) Plasma cell myeloma –Hypo and/or hypercellular marrow was seen with increased lymphocytes and atypical plasma cells. There were 6 cases (3%), (Table 1) which is in the range (1-5.5%) reported by other authors.6, 7, 9, 12, 13 Lymphoma-Three patients in this study presented with lymphoid neoplasia with pancytopenia.(Table 1) Amongst them, one presented with inadequate material on aspiration and diagnosis was made on BMB revealing hypercellular marrow with diffuse effacement by atypical medium sized lymphoid cells in all cases(Figure 7). These findings were comparable to other studies. 6, 14, 15 Thus examination of the BMB is important in the diagnosis and staging of lymphoma.

Metastasis-In present study, 5 cases were detected as metastatic adenocarcinomas on BMB with 2 cases of primary in gastrointestinal tract and 3 cases of prostate carcinoma.(Figure 9) Two of the cases were diagnosed on aspiration smears and three cases were diagnosed by biopsy where aspiration was hypocellular and diluted with peripheral blood(Table 3). 3% metastatic incidence in presence study was very well correlated with Shah P 8 et al and Bahal N 9 et al studies.

Myelodysplastic syndrome (MDS) is defined as cytopenia in peripheral blood with dysplasia in 1 or more cell lineages. 3 Three cases of MDS were detected in present study (Table 1) comparable to Pereira ADS 11 et al and Sweta 13 et al studies. They were diagnosed as refractory cytopenia with dysplasia in peripheral blood. Bone marrow aspiration showed less than 5% blasts with dysplasia in all the three cell lines.

Myelofibrosis Total 4 cases were diagnosed (Table 3). Out of 4, 2 cases were detected by both BMA and BMB procedures. Rest two cases were showing inadequate material and dry tap on aspiration but BMB supported diagnosis. Bone marrow biopsy showed megakaryocytic proliferation with atypia and reticulin and/or collagen fibrosis grades 2 or 3on reticulin staining. In this study, two patients have given significant drug history for rheumatoid arthritis treatment (secondary causes). These results were comparable to Bahal N9 et al, Desalphine M15 et al and Jawalgi A16 et al.

Hypersplenism-there is peripheral pooling of cells with destruction in enlarged spleen occurs resulting in pancytopenia and splenomegaly. Causes are congestive splenomegaly (cirrhosis, congestive heart failure), malaria, leishmaniasis, thalassaemia and hodgkin’s disease.1 Present study had two cases of congestive splenomegaly (Table 1) presented with pancytopenia comparable to other studies. 11, 16

Tuberculosis is common in developing countries like India and disseminated miliary tuberculosis can cause pancytopenia. In this study, one case of tuberculosis was missed on BMA & later granulomas were detected by biopsy showing complimentary role of both procedures to detect focal lesions.(Table 3)

Conclusion

The causes of pancytopenia are diverse and diagnosis of cause is a challenge. Importance must be given to personal, family, nutritional, drugs and alcohol history. Megaloblastic anaemia is leading cause of pancytopenia in India followed by hypoplastic anaemia. Bone marrow aspiration is easy, safe and minimal invasive out patient procedure for evaluation of causes of pancytopenia. BMA and BMB are complimentary to each other if done simultaneously.

The final interpretation is based on the integration of peripheral smear, BMA and BMB study. Clinical features of anemia are observed at the time of detection of pancytopenia. Mean age is approximately 46years with male predilection. Vegetarian population in India should be supplemented with regular intake of cyanocobalamine and folic acid to avoid occurrence of megaloblastic anemia.

Acknowledgement

The authors are very thankful to Dr. Sweta S. Patel (Resident Doctor) for her help in data entry in computer and Dr. Shanti M. Patel (Professor & HOD, pathology dept) for his continuous guidance and support.

Source of Funding   

No financial support was received for the work within this manuscript.

Conflict of Interest

The authors declare they have no conflict of interest.

References

1 

A J Garg A K Agarwal G D Sharma Pancytopenia: Clinical approach. In: the Association of Physicians of IndiaHematol20172114504https://pdfs.semanticscholar.org/8912/eb47447ab887c27a2a44046a11d289c54a80

2 

M D Williams R G Lee J Foerster J Lukens F Paraskevas J P Greer G M Rodgers Ch- Pancytopenia, aplastic anemia and pure red cell aplasiaWintrobe’s Clinical Haematology. 10th Edn.Williams and Wilkins1997144976

3 

E P Weinzierl D A Arber The Differential Diagnosis and Bone Marrow Evaluation of New-Onset PancytopeniaAm J Clin Pathol2013139192910.1309/ajcp50aeeygrewuz

4 

B N Gayathri K S Rao Pancytopenia: A Clinico Hematological StudyJ Lab Physicians2011301152010.4103/0974-2727.78555

5 

V Kumar M Khare M Kishore M Sharma S Marwah A S Nigam Diagnostic Approach of New-Onset Pancytopenia: Study from A Tertiary Care Center Pancytopenia.Ann Pathol Lab Med201858A641610.21276/apalm.1875

6 

R Panigrahi K P Tripathy U Senapati The Aetiological Spectrum of Pancytopenia – A Three Year Clinico-Hematological Study.IOSR J Dent Med Sci201615091091110.9790/0853-150901109111

7 

R Das G Nath Importance of Bone Marrow Examination in Cases of Pancytopenia: A Morphological StudyAnn Pathol Lab Med201636A597604

8 

P Shah R D Patel B Gamit S Gheewala Bone marrow examination in cases of pancytopeniaInt J Res Med Sci2017541494810.18203/2320-6012.ijrms20171253

9 

N Bahal B Thakur A Bhardwaj S Kudesia S Acharya S Kishore Role of Bone Marrow Profile in CytopeniasAnn Pathol Lab Med201635A42732

10 

A V Hoffbrand Ch- Megaloblasticanemias D L Kasper S L Hauser Ch-Megaloblastic anemiasHarrison principles of internal medicine. 19th Edn.New york: McGraw-hill2015640

11 

A D S Pereira A Dias Hematological Analysis of Pancytopenia: A Prospective StudyInt J Scientific Stud201644718https://doi.org/10.17354/ijss/2016/378

12 

R Pathak A Jha G Sayami Evaluation of bone marrow in patients with pancytopeniaJ Pathol Nepal2012242657110.3126/jpn.v2i4.6875

13 

13.Sweta S Barik R K Chandoke A K Verma A prospective clinico-hematological study in 100 cases of pancytopenia in capital city of IndiaJ Appl Hematol201452455010.4103/1658-5127.137139

14 

E Horvath T Mezei Z Pava Diagnostic and differential diagnostic criteria of lymphoid neoplasms in bone marrow trephine biopsies: a study of 87 casesRom. J Morphol Embryol2009503399406

15 

M Desalphine P K Bagga P K Gupta A S Kataria To Evaluate the Role of Bone Marrow Aspiration and Bone Marrow Biopsy in PancytopeniaJ Clin Diagn Res2014811FC11510.7860/jcdr/2014/9042.5169

16 

A P Javalgi V D Dombale Clinico - Hematological Analysis of Pancytopenia: A Bone Marrow StudyNational J Lab Med201324127https://doi.org/NJLM/2013/6782:1995



jats-html.xsl

© 2020 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)